Methylphenidate (‘Ritalin’) can Ameliorate Abnormal Risk-Taking Behavior in the Frontal Variant of Frontotemporal Dementia

[1]  C. Routledge,et al.  Plasma level-dependent effects of methylphenidate on task-related functional magnetic resonance imaging signal changes , 2005, Psychopharmacology.

[2]  Yu-Shin Ding,et al.  Behavioral / Systems / Cognitive Activation of Orbital and Medial Prefrontal Cortex by Methylphenidate in Cocaine-Addicted Subjects But Not in Controls : Relevance to Addiction , 2005 .

[3]  J. T. Coull,et al.  Theα2 antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type , 1996, Psychopharmacology.

[4]  S. Heishman,et al.  Discriminative stimulus effects ofd-amphetamine, methylphenidate, and diazepam in humans , 2005, Psychopharmacology.

[5]  Stefan Poljansky,et al.  Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer's disease , 2004, NeuroImage.

[6]  A. Drzezga,et al.  Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study , 2004, Neurobiology of Aging.

[7]  T. Robbins,et al.  Risk taking during decision-making in normal volunteers changes with age , 2004, Journal of the International Neuropsychological Society.

[8]  T. Robbins,et al.  The neuropsychology of ventral prefrontal cortex: Decision-making and reversal learning , 2004, Brain and Cognition.

[9]  T. Robbins,et al.  Cognitive Inflexibility After Prefrontal Serotonin Depletion , 2004, Science.

[10]  B L Miller,et al.  Behavioral disorders in the frontal and temporal variants of frontotemporal dementia , 2004, Neurology.

[11]  D. Lo Coco,et al.  Frontotemporal dementia presenting with pathological gambling. , 2004, The Journal of neuropsychiatry and clinical neurosciences.

[12]  Antoine Bechara,et al.  Risky Business: Emotion, Decision-Making, and Addiction , 2004, Journal of Gambling Studies.

[13]  Adrian M. Owen,et al.  Dopamine-Dependent Frontostriatal Planning Deficits in Early Parkinson ' s Disease , 2004 .

[14]  B. Sahakian,et al.  Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial , 2004, Psychopharmacology.

[15]  Luke Clark,et al.  The contributions of lesion laterality and lesion volume to decision-making impairment following frontal lobe damage , 2003, Neuropsychologia.

[16]  T. Robbins,et al.  l-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease , 2003, Neuropsychologia.

[17]  Adam R Aron,et al.  Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder , 2003, Biological Psychiatry.

[18]  Andy C. H. Lee,et al.  Associative and recognition memory for novel objects in dementia: implications for diagnosis , 2003, The European journal of neuroscience.

[19]  Karl Herholz,et al.  Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia , 2003, NeuroImage.

[20]  Danielle C. Turner,et al.  Relative lack of cognitive effects of methylphenidate in elderly male volunteers , 2003, Psychopharmacology.

[21]  A. Damasio,et al.  Role of the Amygdala in Decision‐Making , 2003, Annals of the New York Academy of Sciences.

[22]  A. Chatterjee,et al.  Methylphenidate treats apathy in Parkinson's disease. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[23]  W. Schultz.  Getting Formal with Dopamine and Reward , 2002, Neuron.

[24]  J R Hodges,et al.  The prevalence of frontotemporal dementia , 2002, Neurology.

[25]  T. Robbins,et al.  Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set. , 2001, Cerebral cortex.

[26]  Kip Smith,et al.  Neuronal substrates for choice under ambiguity, risk, gains, and losses , 2001, NeuroImage.

[27]  B. Sahakian,et al.  Deficits in decision-making in patients with aneurysms of the anterior communicating artery. , 2000, Brain : a journal of neurology.

[28]  B. Sahakian,et al.  Amelioration of specific working memory deficits by methylphenidate in a case of adult attention deficit/hyperactivity disorder , 2000, Journal of psychopharmacology.

[29]  G. Bartzokis,et al.  Abstinence from Cocaine Reduces High-Risk Responses on a Gambling Task , 2000, Neuropsychopharmacology.

[30]  J. Hodges.  Early-onset dementia : a multidisciplinary approach , 2000 .

[31]  Y. Koshino,et al.  KP1 expression of ghost Pick bodies, amyloid P-positive astrocytes and selective nigral degeneration in early onset Picks disease. , 1999, Clinical neuropathology.

[32]  T. Robbins,et al.  Specific cognitive deficits in mild frontal variant frontotemporal dementia. , 1999, Brain : a journal of neurology.

[33]  T. Robbins,et al.  Dissociable Deficits in the Decision-Making Cognition of Chronic Amphetamine Abusers, Opiate Abusers, Patients with Focal Damage to Prefrontal Cortex, and Tryptophan-Depleted Normal Volunteers: Evidence for Monoaminergic Mechanisms , 1999, Neuropsychopharmacology.

[34]  N. Volkow,et al.  Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. , 1998, The American journal of psychiatry.

[35]  K. Blennow,et al.  Decreased monoamine metabolites in frontotemporal dementia and Alzheimer’s disease , 1998, Neurobiology of Aging.

[36]  J. Hollerman,et al.  Dopamine neurons report an error in the temporal prediction of reward during learning , 1998, Nature Neuroscience.

[37]  D. Berch,et al.  Recovery in Pediatric Brain Injury: Is Psychostimulant Medication Beneficial? , 1998, The Journal of head trauma rehabilitation.

[38]  S. Kish,et al.  Low Thiamine Diphosphate Levels in Brains of Patients with Frontal Lobe Degeneration of the Non‐Alzheimer's Type , 1997, Journal of neurochemistry.

[39]  H. Coslett,et al.  Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial. , 1997, American journal of physical medicine & rehabilitation.

[40]  R. Elliott,et al.  Effects of methylphenidate on spatial working memory and planning in healthy young adults , 1997, Psychopharmacology.

[41]  A. Damasio.  The somatic marker hypothesis and the possible functions of the prefrontal cortex. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[42]  H. Levin,et al.  Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. , 1996, Archives of physical medicine and rehabilitation.

[43]  R. Inoue,et al.  A juvenile case of frontotemporal dementia: Neurochemical and neuropathological investigations , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[44]  Joseph James Duffy,et al.  Apathy: a treatable syndrome. , 1995, The Journal of neuropsychiatry and clinical neurosciences.

[45]  E. Rolls,et al.  Emotion-related learning in patients with social and emotional changes associated with frontal lobe damage. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[46]  Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[47]  M S Mega,et al.  Frontal-subcortical circuits and neuropsychiatric disorders. , 1994, The Journal of neuropsychiatry and clinical neurosciences.

[48]  P. Francis,et al.  Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy. , 1993, Dementia.

[49]  S. Rao,et al.  A double-blind controlled study of methylphenidate treatment in closed head injury. , 1993, Brain injury.

[50]  D. Sparks,et al.  Altered serotonergic and cholinergic synaptic markers in Pick's disease. , 1991, Archives of neurology.

[51]  Gordon D. Logan,et al.  Effects of methylphenidate on inhibitory control in hyperactive children , 1989, Journal of abnormal child psychology.

[52]  S. Heishman,et al.  Discriminative stimulus effects of d-amphetamine, methylphenidate and diazepam in humans , 1989, Pharmacology Biochemistry and Behavior.

[53]  S. Kish,et al.  Dementia, parkinsonism, and motor neuron disease: Neurochemical and neuropathological correlates , 1988, Annals of neurology.

[54]  Evans Rw,et al.  Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury , 1988 .

[55]  R. Oades,et al.  Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity , 1987, Brain Research Reviews.

[56]  D. C. Howell.  Statistical Methods for Psychology , 1987 .

[57]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[58]  D. Benson,et al.  Dementia: A Clinical Approach , 1983 .

[59]  J. Fallon,et al.  Catecholamine innervation of the basal forebrain III. Olfactory bulb, anterior olfactory nuclei, olfactory tubercle and piriform cortex , 1978, The Journal of comparative neurology.

[60]  D. Wilson,et al.  Sequence of neuron origin in experimentally distorted brains of chick embryos , 1978, The Journal of comparative neurology.

[61]  J. Fallon,et al.  Catecholamine innervation of the basal forebrain II. Amygdala, suprarhinal cortex and entorhinal cortex , 1978, The Journal of comparative neurology.

[62]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[63]  A. Bond,et al.  The use of analogue scales in rating subjective feelings , 1974 .

[64]  J. Scheel-Krüger,et al.  Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain. , 1971, European journal of pharmacology.

[65]  C. Conners,et al.  THE EFFECTS OF METHYLPHENIDATE ON SYMPTOMATOLOGY AND LEARNING IN DISTURBED CHILDREN. , 1963, The American journal of psychiatry.

[66]  D. Ellsberg.  Decision, probability, and utility: Risk, ambiguity, and the Savage axioms , 1961 .

[67]  L. Goodman,et al.  THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1966 .